Healthy Living Maine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.

Press releases published on October 22, 2026

11 hours ago

Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

11 hours ago

Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

11 hours ago

Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026

Indeterminate GlobeNewswire

11 hours ago

Ligand to Host Investor Day on December 8, 2026

Indeterminate GlobeNewswire

11 hours ago

Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026

Indeterminate GlobeNewswire

12 hours ago

A Race Against Blindness Celebrates Recent Fundraiser Winners During Blindness Awareness Month

Indeterminate GlobeNewswire

13 hours ago

Foundation for Sarcoidosis Research Welcomes Nine New Members to the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA)

Indeterminate GlobeNewswire

13 hours ago

Nordic Naturals Experts Share the Four Questions Every Consumer Should Ask About Their Supplements

Indeterminate GlobeNewswire

14 hours ago

Dr. Kenneth Pettine, CEO of Direct Regeneration, Unveils Breakthrough Regenerative Technologies Set to Disrupt Orthopedics, Pain Management, and Skincare

Indeterminate GlobeNewswire

14 hours ago

IQity Draws Strong Surgeon Interest at First Exhibition Debut, AAO 2026

Indeterminate GlobeNewswire

15 hours ago

SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI

Indeterminate GlobeNewswire

15 hours ago

One04 Therapeutics presents positive interim Phase 1 data for CPV-104 in C3 glomerulopathy in ASN Kidney Week late-breaker

Indeterminate GlobeNewswire

15 hours ago

Walden Biosciences Announces Positive Data from Diabetic Kidney Disease Cohorts in Ongoing Phase 2 Study of WAL0921

Indeterminate GlobeNewswire

15 hours ago

InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026

Indeterminate GlobeNewswire

15 hours ago

WHAT 3,000 EMPLOYERS AND PARENTS IN AMERICA’S HEARTLAND TOLD US ABOUT PAID PARENTAL LEAVE

Indeterminate GlobeNewswire

15 hours ago

Guerbet : Revenue at 30 September 2026.

Indeterminate GlobeNewswire

15 hours ago

Guerbet : Chiffre d’affaires au 30 septembre 2026.

Indeterminate GlobeNewswire

15 hours ago

Global Organoids and Spheroids Market to Reach $2.8 Billion by 2031

Indeterminate GlobeNewswire

16 hours ago

Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors

Indeterminate GlobeNewswire

17 hours ago

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine

Indeterminate GlobeNewswire